Brainowl’s ‘Free’ IQ Test
“Free” offer could prove costly.
A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca. They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium. In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)
“Free” offer could prove costly.
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Consumers balk at hidden junk fees.
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.